BRCA1/2 Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients

Michalis Liontos; Eleni Zografos; Panagiotis Zoumpourlis; Αngeliki Andrikopoulou; Anna Svarna; Oraianthi Fiste; Elena Kunadis; Alkistis Papatheodoridi; Maria Kaparelou; Konstantinos Koutsoukos; N Thomakos; Dimitrios Haidopoulos; Alexandros Rodolakis; Meletios A Dimopoulos; Flora Zagouri

doi:10.3390/curroncol28060377

Article2013

Correction: Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases

Alexandra Stavropoulou, Florentia Fostira, Maroulio Pertesi, Marianthi Tsitlaidou, Gerassimos E. Voutsinas, Olga Triantafyllidou, Aristotelis Bamias, Meletios A Dimopoulos, Eleni Timotheadou, Dimitrios Pectasides, Christos Christodoulou, G. Klouvas, Christos Papadimitriou, Thomas Makatsoris, George Pentheroudakis, Gerasimos Aravantinos, Vassilis Karydakis, Drakoulis Yannoukakos, George Fountzilas, Irene Konstantopoulou

Article2013

Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases

Alexandra Stavropoulou, Florentia Fostira, Maroulio Pertesi, Marianthi Tsitlaidou, Gerassimos E. Voutsinas, Olga Triantafyllidou, Aristotelis Bamias, Meletios A Dimopoulos, Eleni Timotheadou, Dimitrios Pectasides, Christos Christodoulou, G. Klouvas, Christos Papadimitriou, Thomas Makatsoris, George Pentheroudakis, Gerasimos Aravantinos, Vassilis Karydakis, Drakoulis Yannoukakos, George Fountzilas, Irene Konstantopoulou

Article2014

Abstract 5483: Implications of the type of BRCA1 germline mutation in the treatment of patients with hereditary breast cancer

Tereza Vaclová, Nicholas T. Woods, Fernando Setién, José María García Bueno, José A. Macías, Alicia Barroso, Miguel Urioste, Manel Esteller, Álvaro N.A. Monteiro, Javier Benı́tez, Ana Osório

Article2012

BRCA1epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer

Ólafur Andri Stefánsson, Alberto Villanueva, August Vidal, Lola Martí, Manel Esteller

Preprint2023

Data from Efficacy of Chemotherapy in BRCA1/2 Mutation Carrier Ovarian Cancer in the Setting of PARP Inhibitor Resistance: A Multi-Institutional Study

Joo Ern Ang, Charlie Gourley, C. Bethan Powell, Hilda High, Ronnie Shapira-Frommer, Vincent Castonguay, Jacques De Grève, Tina Atkinson, Timothy A. Yap, Shahneen Sandhu, Susana Banerjee, Lee-may Chen, Michael Friedlander, Bella Kaufman, Amit M. Oza, Ursula A. Matulonis, Louise J. Barber, Iwanka Kozarewa, Kerry Fenwick, Ioannis Assiotis, James R. Campbell,

BRCA1/2 Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients

Abstract

Discussion(0)

Related publications

Correction: Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases

Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases

Abstract 5483: Implications of the type of <i>BRCA1</i> germline mutation in the treatment of patients with hereditary breast cancer

<i>BRCA1</i>epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer

Data from Efficacy of Chemotherapy in <i>BRCA1/2</i> Mutation Carrier Ovarian Cancer in the Setting of PARP Inhibitor Resistance: A Multi-Institutional Study

BRCA1/2 Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients

Abstract

Discussion(0)

Related publications

Correction: Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases

Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases

Abstract 5483: Implications of the type of <i>BRCA1</i> germline mutation in the treatment of patients with hereditary breast cancer

<i>BRCA1</i>epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer

Data from Efficacy of Chemotherapy in &lt;i&gt;BRCA1/2&lt;/i&gt; Mutation Carrier Ovarian Cancer in the Setting of PARP Inhibitor Resistance: A Multi-Institutional Study

Data from Efficacy of Chemotherapy in <i>BRCA1/2</i> Mutation Carrier Ovarian Cancer in the Setting of PARP Inhibitor Resistance: A Multi-Institutional Study